Document Detail

Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke.
MedLine Citation:
PMID:  18416997     Owner:  NLM     Status:  MEDLINE    
C-reactive protein (CRP), an inflammatory marker, has been identified as a likely predictor of the risk of a future stroke. In clinical settings, it has been consistently observed that higher concentrations of CRP are associated with larger brain infarcts and worst neurologic outcome. However, there is still controversy over the degree of risk conferred by elevated CRP concentrations. CRP, like many other hemostatic factors, is an acute-phase protein and, therefore, it is not always clear whether its association with cerebrovascular disease reflects its contribution to atherothrombosis, its acute-phase condition, or both. Whether a reduction of CRP levels could be beneficial to stroke patients remains to be clarified. More studies are needed before CRP becomes a routine part of the evaluation of stroke patients.
Jerzy Krupinski; Marta M Turu; Mark Slevin; José Martínez-González
Related Documents :
18339787 - C-reactive protein levels and survival in patients with moderate to very severe copd.
21204907 - Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients p...
17452737 - Cytokines and c-reactive protein production in hip-fracture-operated elderly patients.
10888707 - The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tum...
22591107 - Serum holotranscobalamine, vitamin b12, folic acid and homocysteine levels in alopecia ...
2109557 - Eucapnia and hypercapnia in patients with chronic airflow limitation. the role of the u...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current cardiology reports     Volume:  10     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-04-17     Completed Date:  2008-06-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  25-30     Citation Subset:  IM    
Department of Neurology, Stroke Unit, Hospital Universitari de Bellvitge, Feixa Llarga s/n 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / therapeutic use
Brain Ischemia / blood,  drug therapy,  physiopathology*
C-Reactive Protein / metabolism*
Carotid Arteries / pathology*,  physiopathology
Carotid Artery Diseases / blood,  pathology*,  physiopathology
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Platelet Aggregation Inhibitors / therapeutic use
Risk Factors
Stroke / blood,  drug therapy,  physiopathology*
Reg. No./Substance:
0/Antihypertensive Agents; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Platelet Aggregation Inhibitors; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Indications for carotid artery surgery and stent: the role of carotid ultrasound.
Next Document:  Aortic occlusion for cerebral ischemia: from theory to practice.